Research ArticleOriginal Articles
Open Access

Risk factors of multiple sclerosis in Aseer region, Kingdom of Saudi Arabia A case-control study

Aesha F. Siddiqui, Abdullah A. Alsabaani, Ahmed Y. Abouelyazid and Yasser I. Wassel
Neurosciences Journal January 2021, 26 (1) 69-76; DOI: https://doi.org/10.17712/nsj.2021.1.20200107

References

  1. ↵
    1. Dendrou CA,
    2. Fugger L,
    3. Friese MA
    (2015) Immunopathology of multiple sclerosis 20. Nat Rev Immunol 15:545–558.
    OpenUrlCrossRefPubMed
    1. Sakoda A,
    2. Matsushita T,
    3. Nakamura Y,
    4. Watanabe M,
    5. Shinoda K,
    6. Masaki K,
    7. et al.
    (2019) Environmental risk factors for multiple sclerosis in Japanese people. Mult Scler Relat Disord 38:101872.
    OpenUrl
  3. ↵
    1. Marrodan M,
    2. Alessandro L,
    3. Farez MF,
    4. Correale J
    (2019) The role of infections in multiple sclerosis. Mult Scler J 25:891–901.
    OpenUrl
  4. ↵
    1. Alfredsson L,
    2. Olsson T
    (2019) Lifestyle and Environmental Factors in Multiple Sclerosis. Cold Spring Harb Perspect Med 9:a028944.
    OpenUrlAbstract/FREE Full Text
  5. ↵
    1. Patsopoulos NA
    (2018) Genetics of multiple sclerosis:an overview and new directions. Cold Spring Harb Perspect Med 8:a028951.
    OpenUrlAbstract/FREE Full Text
  6. ↵
    1. Degelman M.L,
    2. Herman K.M
    (2017) Smoking and multiple sclerosis:a systematic review and meta-analysis using the Bradford Hill criteria for causation. Mult Scler Relat Disord 17:207–216.
    OpenUrl
  7. ↵
    1. Berg HP,
    2. Celius EG
    (2015) Socioeconomic factors and immigrant population studies of multiple sclerosis. Acta Neurol Scand 132:37–41.
    OpenUrl
  8. ↵
    1. Hedström A.K,
    2. Olsson T,
    3. Alfredsson L
    (2016) Smoking is a major preventable risk factor for multiple sclerosis. Mult Scler 22:1021–1026.
    OpenUrlCrossRefPubMed
  9. ↵
    1. Poorolajal J,
    2. Bahrami M,
    3. Karami M,
    4. Hooshmand E
    (2017) Effect of smoking on multiple sclerosis:a meta-analysis. J Public Health (Oxf) 39:312–320.
    OpenUrl
  10. ↵
    1. Bar-Or A,
    2. Pender MP,
    3. Khanna R,
    4. Steinman L,
    5. Hartung HP,
    6. Maniar T
    (2020) Epstein–Barr virus in multiple sclerosis:theory and emerging immunotherapies. Trends Mol Med 26:296–310.
    OpenUrlCrossRef
  11. ↵
    1. Venkatesan A,
    2. Johnson RT
    (2014) Infections and multiple sclerosis. Handb Clin Neurol 122:151–171.
    OpenUrlCrossRefPubMed
  12. ↵
    1. Kattimani Y,
    2. Veerappa AM
    (2018) Complex interaction between mutant HNRNPA1 and gE of varicella zoster virus in pathogenesis of multiple sclerosis. Autoimmunity 51:147–151.
    OpenUrlCrossRef
  13. ↵
    1. Cavallo S
    (2020) Immune-mediated genesis of multiple sclerosis. J Transl Autoimmun 3:100039.
    OpenUrl
  14. ↵
    1. Brenton JN,
    2. Engel CE,
    3. Sohn MW,
    4. Goldman MD
    (2017) Breastfeeding during infancy is associated with a lower future risk of pediatric multiple sclerosis. Pediatr Neurol 77:67–72.
    OpenUrl
  15. ↵
    1. Conradi S,
    2. Malzahn U,
    3. Paul F,
    4. Quill S,
    5. Harms L,
    6. Bergh FT,
    7. et al.
    (2013) Breastfeeding is associated with lower risk for multiple sclerosis. Mult Scler 19:553–558.
    OpenUrlCrossRefPubMed
  16. ↵
    1. Browne P,
    2. Chandraratna D,
    3. Angood C,
    4. Tremlett H,
    5. Baker C,
    6. Taylor BV,
    7. et al.
    (2014) Atlas of multiple sclerosis 2013:a growing global problem with widespread inequity. Neurology 83:1022–1024.
    OpenUrlCrossRefPubMed
  17. ↵
    1. Sahraian MA,
    2. Sahebkar M,
    3. Dehghani R,
    4. Derakhshan-Jazari M,
    5. Kazami-Moghaddam V,
    6. Kouchaki E
    (2017) Multiple sclerosis- A disease on a dramatically rising trend in Iran:Review of possible reasons. Iran J Neurol 16:34–40.
    OpenUrl
  18. ↵
    1. Deleu D,
    2. Mir D,
    3. Al Tabouki A,
    4. Mesraoua R,
    5. Mesraoua B,
    6. Akhtar N,
    7. et al.
    (2013) Prevalence, demographics and clinical characteristics of multiple sclerosis in Qatar. Mult Scler 19:816–819.
    OpenUrlCrossRefPubMed
  19. ↵
    1. Alroughani R,
    2. Ahmed SF,
    3. Behbahani R,
    4. Khan R,
    5. Thussu A,
    6. Alexander KJ,
    7. et al.
    (2014) Increasing prevalence and incidence rates of multiple sclerosis in Kuwait. Mult Scler 20:543–547.
    OpenUrlCrossRefPubMed
  20. ↵
    1. Correale J,
    2. Farez MF,
    3. Inés M
    (2017) Environmental factors influencing multiple sclerosis in Latin America. Mult Scler J- Exp Transl Clin 3:2055217317715049.
    OpenUrl
  21. ↵
    1. Al-Shammri SN,
    2. Hanna MG,
    3. Chattopadhyay A,
    4. Akanji AO
    (2015) Sociocultural and demographic risk factors for the development of multiple sclerosis in Kuwait:a case-control study. PLoS One 10:e0132106.
    OpenUrl
    1. Gustavsen MW,
    2. Page CM,
    3. Moen SM,
    4. Bjolgerud A,
    5. Berg-Hansen P,
    6. Nygaard GO,
    7. et al.
    (2014) Environmental exposures and the risk of multiple sclerosis investigated in a Norwegian case-control study. BMC Neurol 14:196.
    OpenUrl
    1. Poorolajal J,
    2. Mazdeh M,
    3. Saatchi M,
    4. Talebi Ghane E,
    5. Biderafsh A,
    6. Lotfi B,
    7. et al.
    (2015) Multiple sclerosis associated risk factors:A case-control study. Iran J Public Health 44:1498–1505.
    OpenUrlPubMed
  24. ↵
    1. El-Muzaini H,
    2. Akhtar S,
    3. Alroughani R
    (2020) A matched case-control study of risk factors associated with multiple sclerosis in Kuwait. BMC Neurol 20:306.
    OpenUrl
  25. ↵
    1. Al-Abdullah MS,
    2. Siddiqui AF
    (2018) Demographic and disease characteristics of multiple sclerosis in the Southwest Region of Saudi Arabia. Neurosciences (Riyadh) 23:320–325.
    OpenUrl
  26. ↵
    1. Waubant E,
    2. Lucas R,
    3. Mowry E,
    4. Graves J,
    5. Olsson T,
    6. Alfredsson L,
    7. et al.
    (2019) Environmental and genetic risk factors for MS:an integrated review. Ann Clin Transl Neurol 6:1905–1922.
    OpenUrl
  27. ↵
    1. Etemadifar M,
    2. Nourian SM,
    3. Nourian NS,
    4. Abtahi SH,
    5. Sayahi F,
    6. Saraf Z,
    7. et al.
    (2016) Early-onset multiple sclerosis in Isfahan, Iran:report of the demographic and clinical features of 221 patients. J Child Neurol 31:932–937.
    OpenUrlCrossRefPubMed
  28. ↵
    1. Al Jumah M,
    2. Bunyan R,
    3. Al Otaibi H,
    4. Al Towaijri G,
    5. Karim A,
    6. Al Malik Y,
    7. et al.
    (2020) Rising prevalence of multiple sclerosis in Saudi Arabia, a descriptive study. BMC Neurol 20:49.
    OpenUrl
  29. ↵
    1. Al-Jumah M,
    2. Kojan S,
    3. Khathaami AA,
    4. Abdulkaream IA,
    5. Blawi MA,
    6. Jawhary A
    (2011) Familial multiple sclerosis:does consanguinity have a role? Mult Scler J 17:487–489.
    OpenUrl
  30. ↵
    1. Sintzel MB,
    2. Rametta M,
    3. Reder AT
    (2018) Vitamin D and multiple sclerosis:a comprehensive review. Neurol Ther 7:59–85.
    OpenUrl
  31. ↵
    1. Jagannath VA,
    2. Filippini G,
    3. Di Pietrantonj C,
    4. Asokan GV,
    5. Robak EW,
    6. Whamond L,
    7. Robinson SA
    (2018) Vitamin D for the management of multiple sclerosis. Cochrane Database Syst Rev 9:CD008422.
    OpenUrlPubMed
  32. ↵
    1. Al-Yatama FI,
    2. AlOtaibi F,
    3. Al-Bader MD,
    4. Al-Shoumer KA
    (2019) The Effect of Clothing on Vitamin D Status, Bone Turnover Markers, and Bone Mineral Density in Young Kuwaiti Females. Int J Endocrinol 2019:6794837.
    OpenUrlPubMed
  33. ↵
    1. Sampat N,
    2. Al-Balushi B,
    3. Al-Subhi L,
    4. Al-Adawi S,
    5. Essa MM,
    6. Walid Qoronfleh M
    (2019) Vitamin D:Public Health Status Regional Gulf Region. Int J Nutr Pharmacol Neurol Dis 9:117–135.
    OpenUrl
  34. ↵
    1. Moghadam VM
    (2010) Urbanization and women's citizenship in the Middle East. Brown Journal of World Affairs 17:19–34.
    OpenUrl
  35. ↵
    1. Rosso M,
    2. Chitnis T
    (2020) Association between cigarette smoking and multiple sclerosis:a review. JAMA Neurol 77:245–253.
    OpenUrl
  36. ↵
    1. Marrie RA,
    2. Reider N,
    3. Cohen J,
    4. Stuve O,
    5. Sorensen PS,
    6. Cutter G,
    7. et al.
    (2015) A systematic review of the incidence and prevalence of autoimmune disease in multiple sclerosis. Mult Scler 21:282–293.
    OpenUrlCrossRefPubMed
  37. ↵
    1. Azami M,
    2. YektaKooshali MH,
    3. Shohani M,
    4. Khorshidi A,
    5. Mahmudi L
    (201) Correction:Epidemiology of multiple sclerosisin Iran:A systematic review and meta-analysis. PLoS One 14:e0219466.
  38. ↵
    1. Li C,
    2. Liu Y,
    3. Jiang Y,
    4. Xu N,
    5. Lei J
    (2017) Immunomodulatory constituents of human breast milk and immunity from bronchiolitis. Ital J Pediatr 43:8.
    OpenUrl
Back to top

In this issue

Print
Download PDF
Email Article
Citation Tools
Bookmark this article

Jump to section